Junying Xu

1.6k total citations
72 papers, 1.1k citations indexed

About

Junying Xu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Junying Xu has authored 72 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Junying Xu's work include Cancer Immunotherapy and Biomarkers (14 papers), Ferroptosis and cancer prognosis (8 papers) and Regulation of Appetite and Obesity (6 papers). Junying Xu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Ferroptosis and cancer prognosis (8 papers) and Regulation of Appetite and Obesity (6 papers). Junying Xu collaborates with scholars based in China, United States and Hong Kong. Junying Xu's co-authors include Jiande D. Z. Chen, Chaoying Liu, Chujun Zhao, Jiao Yang, Yiwei Chu, Feifei Luo, Bo Wang, Yuedi Wang, Ronghua Liu and Chen Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Chemical Engineering Journal.

In The Last Decade

Junying Xu

67 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junying Xu China 21 376 361 240 223 189 72 1.1k
Wenyong Long China 16 172 0.5× 961 2.7× 144 0.6× 166 0.7× 375 2.0× 38 1.5k
Zhigang He China 24 263 0.7× 573 1.6× 214 0.9× 137 0.6× 280 1.5× 92 1.8k
Jing Lv China 17 216 0.6× 601 1.7× 66 0.3× 235 1.1× 308 1.6× 87 1.3k
Michael Jung Germany 16 249 0.7× 406 1.1× 88 0.4× 300 1.3× 205 1.1× 26 1.1k
Holly C. Williams United States 16 291 0.8× 642 1.8× 240 1.0× 190 0.9× 279 1.5× 25 1.4k
Zhonghui Liu China 23 168 0.4× 702 1.9× 215 0.9× 161 0.7× 174 0.9× 91 1.3k
Liang Guo China 24 528 1.4× 1.0k 2.8× 295 1.2× 202 0.9× 499 2.6× 98 2.1k
Lifen Yang China 22 192 0.5× 553 1.5× 269 1.1× 75 0.3× 91 0.5× 82 1.5k
Meenakshi B. Bhattacharjee United States 19 210 0.6× 662 1.8× 97 0.4× 99 0.4× 73 0.4× 59 1.4k
Xue Yao China 23 111 0.3× 825 2.3× 155 0.6× 403 1.8× 375 2.0× 65 1.9k

Countries citing papers authored by Junying Xu

Since Specialization
Citations

This map shows the geographic impact of Junying Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junying Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junying Xu more than expected).

Fields of papers citing papers by Junying Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junying Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junying Xu. The network helps show where Junying Xu may publish in the future.

Co-authorship network of co-authors of Junying Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Junying Xu. A scholar is included among the top collaborators of Junying Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junying Xu. Junying Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xi, Cenzhu Wang, Hong Fan, et al.. (2025). Tumor‑associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review). International Journal of Oncology. 66(4). 1–16. 4 indexed citations
2.
Mei, Jie, Yun Cai, Ying Jiang, et al.. (2024). High B7-H3 expression with low PD-L1 expression identifies armored-cold tumors in triple-negative breast cancer. npj Breast Cancer. 10(1). 11–11. 25 indexed citations
3.
Mei, Jie, Yun Cai, Rui Xu, et al.. (2024). Conserved immuno‐collagenic subtypes predict response to immune checkpoint blockade. Cancer Communications. 44(5). 554–575. 23 indexed citations
4.
5.
Luo, Zhiwen, Jie Mei, Xianwen Wang, et al.. (2024). Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironment. Cell Reports. 43(9). 114697–114697. 36 indexed citations
6.
Zhang, Youhui, Jiawei Deng, Sang Young Jeong, et al.. (2023). Facilely full-end-capping engineering promotes high-performance organic solar cells with simultaneously improved efficiency and stability. Chemical Engineering Journal. 457. 141343–141343. 12 indexed citations
7.
Ding, Junli, Hao Wang, Yuting Li, et al.. (2023). Total T Cell Density and Expression of T Memory Stem Cell Markers are Associated with Better Prognosis in Colon Cancer. International Journal of General Medicine. Volume 16. 2285–2294. 2 indexed citations
8.
Mei, Jie, Ziyi Fu, Yun Cai, et al.. (2023). SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers. iScience. 26(2). 106027–106027. 12 indexed citations
9.
Xu, Junying, Fen Li, Junfeng Zhang, et al.. (2023). The interleukin enhancer binding factor-2 (ILF2) gene in Penaeus japonicus shrimp: cloning, tissue distribution, and antiviral effects. Aquaculture International. 32(2). 1051–1065. 1 indexed citations
10.
Wang, Xiaowei, et al.. (2023). Investigation on the interaction of aromatic organophosphate flame retardants with human serum albumin via computer simulations, multispectroscopic techniques and cytotoxicity assay. International Journal of Biological Macromolecules. 247. 125741–125741. 21 indexed citations
11.
Xu, Junying, Jun Hou, Lianghai Wang, et al.. (2023). EgCF mediates macrophage polarisation by influencing the glycolytic pathway. Journal of Helminthology. 97. e101–e101. 1 indexed citations
12.
Xu, Junying, et al.. (2021). LncRNA TUG1 regulates the development of ischemia-reperfusion mediated acute kidney injury through miR-494-3p/E-cadherin axis. Journal of Inflammation. 18(1). 12–12. 29 indexed citations
13.
Ding, Junli, et al.. (2021). Research Progress of Immunoscore in Prediction of Tumor Prognosis and Efficacy to Treatment. SHILAP Revista de lepidopterología. 48(8). 809–813. 1 indexed citations
14.
Zhang, Yaru, Ruiling Xu, Fanghao Wang, et al.. (2021). Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis. Cardiovascular Drugs and Therapy. 35(5). 1057–1066. 20 indexed citations
15.
Liu, Shuai, Hao Wu, Zhichao Chen, et al.. (2021). The Impact of the COVID-19 Pandemic on Alzheimer's Disease and Other Dementias. Frontiers in Psychiatry. 12. 703481–703481. 23 indexed citations
16.
Dong, Hua, Junying Xu, Yadan Xu, et al.. (2019). OA03.01 A Non-Randomized, Open-Label, Prospective, Multicenter Study of Apatinib as Second-Line and Later-Line Therapy in Patients with ES-SCLC. Journal of Thoracic Oncology. 14(10). S210–S211. 2 indexed citations
17.
Qian, Jiawen, Chen Wang, Bo Wang, et al.. (2018). The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy. Journal of Neuroinflammation. 15(1). 290–290. 207 indexed citations
18.
Xu, Junying, Terry A. McNearney, & J. D. Z. Chen. (2010). Impaired postprandial releases/syntheses of ghrelin and PYY 3‐36 and blunted responses to exogenous ghrelin and PYY 3‐36 in a rodent model of diet‐induced obesity. Journal of Gastroenterology and Hepatology. 26(4). 700–705. 20 indexed citations
19.
Chen, Wen, et al.. (2007). Effect of Resveratrol on Growth and Apoptosis of Human Esophageal Cancer Cells. 1 indexed citations
20.
Xu, Junying, et al.. (2007). Roles of putative neurotransmitters in the regulation of gastric and intestinal slow waves in conscious dogs. Journal of Gastroenterology and Hepatology. 22(7). 1044–1050. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenyong Long Breakdown of academic impact, for papers by Zhigang He Breakdown of academic impact, for papers by Jing Lv Breakdown of academic impact, for papers by Michael Jung Breakdown of academic impact, for papers by Holly C. Williams Breakdown of academic impact, for papers by Zhonghui Liu Breakdown of academic impact, for papers by Liang Guo Breakdown of academic impact, for papers by Lifen Yang Breakdown of academic impact, for papers by Meenakshi B. Bhattacharjee Breakdown of academic impact, for papers by Xue Yao
Rankless by CCL
2026